Pharmaceuticals

Johnson & Johnson to Acquire V-Wave Ltd

bexib
By bexib 0 Min Read

The acquisition, valued at $600 million, will see V-Wave integrated into Johnson & Johnson MedTech and could improve treatment of heart failure with reduced ejection fraction.

You Might Also Like

Drugs hit hardest in Medicare price negotiations

Imfinzi improves survival in patients with limited-stage small cell lung cancer, according to Phase 3 data presented at ASCO

Cambridge researchers develop robotic neurological device for neurological conditions

Pharma Pulse 8/2/24: Poor-quality data a population health risk, Meta revenue eases AI fears, and more

To overcome barriers, cell and gene therapy needs outside help

Share This Article
Previous Article Matt Zwolinski on moral equality
Next Article Retrocomputing: Old Tech, New Thrills
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Techcombank’s digital channels drive growth to 15 million users in 2024
Fintech
Top 10 largest fintech acquisitions in Southeast Asia
Fintech
Revolut launches robo-advisor in Singapore
Fintech
This hurricane season, do your customers know the difference between homeowners insurance and flood insurance?
Insurance